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Glucose homeostasis is maintained through interplay between central and peripheral
control mechanisms which are aimed at storing excess glucose following meals and
mobilizing these same stores during periods of fasting. The nucleus of the solitary tract
(NST) in the dorsal medulla has long been associated with the central detection of glucose
availability and the control of glucose homeostasis. Recent evidence has emerged which
supports the involvement of astrocytes in glucose homeostasis. The aim of the present
study was to investigate whether NST-astrocytes respond to physiologically relevant
decreases in glucose availability, in vitro, as well as to the presence of the glucoprivic
compound 2-deoxy-D-Glucose. This report demonstrates that some NST-astrocytes are
capable of responding to low glucose or glucoprivation by increasing cytoplasmic calcium;
a change that reverses with restoration of normal glucose availability. While some
NST-neurons also demonstrate an increase in calcium signaling during low glucose
availability, this effect is smaller and somewhat delayed compared to those observed
in adjacent astrocytes. TTX did not abolish these hypoglycemia mediated responses of
astrocytes, suggesting that NST-astrocytes may be directly sensing low glucose levels as
opposed to responding to neuronal detection of hypoglycemia. Thus, chemodetection of
low glucose by NST-astrocytes may play an important role in the autonomic regulation of
glucose homeostasis.
Keywords: astrocytes, calcium imaging, 2-deoxy-D-glucose, solitary nucleus, vago-vagal reflex, glucose
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INTRODUCTION
Glucose is the primary energy source for cellular metabolism.
Therefore, the maintenance of appropriate serum glucose levels
is critical for organismal survival. Glucose homeostasis is main-
tained through interplay between central and peripheral control
mechanisms which are aimed at storing excess glucose following
meals and mobilizing these same stores during periods of fast-
ing. Central control of glucose homeostasis is accomplished by
a distributed system of glucosensing elements, integrative neu-
ral networks which process signals from these elements, and
pre-autonomic nuclei which control motor outflow and are mod-
ulated through inputs from these neural integrators (Watts and
Donovan, 2010).
A principal site for neural integration of glucose availabil-
ity is the nucleus of the solitary tract (NST), located in the
dorsal medulla. Cells within NST have unique access to serum
glucose levels due to the large numbers of fenestrated capil-
laries present in the nucleus (Gross et al., 1990) as well as its
close apposition to the area postrema, a circumventricular organ
(Cottrell and Ferguson, 2004). A subset of NST neurons have
been shown to respond to physiologically relevant changes in
extracellular glucose availability both in vivo (Yettefti et al., 1995,
1997) and in vitro (Mizuno and Oomura, 1984; Himmi et al.,
1996; Dallaporta et al., 1999). In addition to containing these glu-
coresponsive cells, NST also receives input regarding peripheral
glucose levels by way of glucosensors located in hepatic por-
tal/mesenteric vein, which innervate NST via the hepatic branch
of the vagus nerve (Niijima, 1984; Adachi et al., 1995; Grabauskas
et al., 2010). Furthermore, NST also receives descending inputs
from hypothalamic nuclei such as the lateral and paraventricular
nuclei that are associated with glucose homeostasis (Marty et al.,
2007; Geerling et al., 2010; Biag et al., 2012). Due to this conflu-
ence of signals regarding glucose availability as well as its inputs to
pre-autonomic nuclei, the NST plays a predominate role in cen-
tral control of glucose homeostasis (Adachi et al., 1995; Grill and
Hayes, 2012).
The NST is also commonly associated with the physiological
response to hypoglycemia. These autonomic counter-measures,
often referred to collectively as the counter-regulatory response
(CRR) include increases in serum levels of glucagon and stress
hormones, increased food intake, and an overall increase in sym-
pathetic tone. Systemic administration of the glucoprivic com-
pound 2-deoxy-glucose (2-DG; a glucose analog commonly used
to invoke the CRR) results in increased c-Fos expression in the
NST (Ritter et al., 1998; Briski and Marshall, 2000; Sanders and
Ritter, 2000; Dodd et al., 2010). Focal administration of a simi-
lar glucoprivic agent, 5-thio-D-glucose, directly into the NST of
rats also drives CRRs such as increased food intake (Ritter et al.,
2000) and increases in serum glucagon and stress hormone levels
(Andrew et al., 2007).
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In addition to its role in glucose homeostasis and
hypoglycemic counter-regulation, the NST plays a critical
role in a number of other autonomic functions such as reg-
ulation of cardiovascular, respiratory, and gastrointestinal
reflexes (Blessing, 1997). There is increasing evidence that
chemodetection by brainstem astrocytes can drive changes
in these autonomic reflexes (Hermann and Rogers, 2009;
Hermann et al., 2009; Gourine et al., 2010; Kasymov et al.,
2013). Interestingly there is also strong evidence for astrocytic
involvement in the autonomic response to hypoglycemia.
Systemic administration of the selective glial toxin, methionine
sulfoximine, blocks 2-DG induced c-Fos expression in NST
(Young et al., 2000). In addition, transgenic mice which only
express the type II glucose transporter (GLUT2) in pancre-
atic beta cells (i.e., expression of GLUT2 was knocked out
centrally), demonstrate defects in the CRR (Burcelin and
Thorens, 2001). However, these defects are rescued by the
selective CNS re-expression of GLUT2 in astrocytes, but not
neurons (Marty et al., 2005). Therefore, the aim of the present
study was to investigate whether NST-astrocytes respond
to physiologically relevant decreases in glucose availability,
in vitro, as well as to the presence of the glucoprivic compound
2-DG.
METHODS
ANIMALS
All experimental procedures were conducted under the approval
of the Pennington Biomedical Research Center’s Institutional
Animal Care and Use Committee. Long Evans rats of either sex
(body weight between 150 and 250 g) were used in these stud-
ies. All animals were housed in a temperature controlled room
under 12 h light/dark cycle and provided water and food ad libi-
tum. All experimental protocols were performed according to the
guidelines set forth by the National Institutes of Health.
In vivo PRE-LABELING OF NST AND HARVEST OF HINDBRAIN SLICES
Animals (N = 22) were deeply anesthetized with urethane (1.5
g/kg, ip; ethyl carbamate, Sigma) and placed in a stereotaxic
frame. Using aseptic technique, the occipital plate of the skull
was removed to expose the medullary brainstem. A micropipette
30 micron tip diameter; filled with 0.2% Calcium Green 1 AM
(CAG; Life Technologies), 0.3% sulforhodamine 101 (SR101;
Sigma Chemical) and 20% pluronic-DMSO (F-127, in pH 7.2
tris-PBS buffer) was directed toward the medial solitary nucleus
using a stereotaxic carrier. Four injections (40 nL each) of the
CAG-SR101 solution were made unilaterally into the NST at the
level of calamus and 0.2, 0.4, and 0.6mm anterior to calamus; all
at a depth of 300 microns below the surface. This injection pat-
tern labeled the entire ipsilateral medial NST (Hermann et al.,
2009). CAG, a calcium reporter dye, is taken up by both neu-
rons and glia while SR101 labels only astrocytes (Nimmerjahn
et al., 2004; McDougal et al., 2011). SR101 does not interfere with
CAG fluorescence (Hermann and Rogers, 2009). Thus, despite
the similarity in size of NST neuronal and astrocytic cell bod-
ies, this method made it possible to easily discriminate between
these two cell types in the slice preparation (Figure 1). After a
30min interval to allow for dye uptake, the anesthetized rat was
FIGURE 1 | Live cell calcium imaging of NST astrocytes in response to
glucoprivic challenge. In vivo co-injection of the calcium indicator dye,
Calcium Green 1-AM (CAG; green) and the glial vital stain sulforhodamine
101 (SR101; red) allows for simple discrimination of astrocytes and neurons
in the in situ brain stem slice preparation. Following a dual exposure
utilizing the 488 nm and 561 nm laser lines, a composite image is obtained
in which astrocytes are clearly labeled yellow, i.e., positive for both CAG
and SR101, while neurons remain green (A). Time-lapse imaging with only
the 488 nm laser line can then be used to follow changes in intracellular
calcium concentrations, indicated by a proportional change in the intensity
of the CAG signal, before, during, and after the application of glucoprivic or
low glucose challenges. Regions of interest (ROI) were drawn around an
individual neuron (blue circle) and astrocyte (red circle) in (A) for analysis of
their time-lapse responses to 2-DG challenge (B). Exposure time to 2-DG is
represented by bar over graph.
decapitated and the brainstem was quickly harvested. The cau-
dal brainstem was glued to an aluminum block and placed in
cold (∼4◦C) carboxygenated (95% O2; 5% CO2) cutting solu-
tion (recipe below). Coronal sections (300 micron thick) were cut
through the medulla using a Leica VT1200 tissue slicer equipped
with a sapphire knife (Delaware Diamond Knives). The NST is
easily identified in these slices due to its lack of myelin; 4–5 slices
containing NST were collected from each animal and placed in
normal Krebs’ solution (recipe below) which was bubbled with
95% O2/5% CO2 and maintained at a constant temperature of
29◦C. Slices were allowed to equilibrate to these conditions for an
hour prior to imaging.
In vitro DRUGS AND SOLUTIONS
All solutions were freshly prepared on the day of the experi-
ment. The cutting solution contained 110mM choline chloride,
25mM NaHCO3, 2.5mM KCl, 7mM MgSO4–7H2O, 1.25mM
NaH2PO4, 10mM glucose, and 0.5mM CaCl2–2H2O. The nor-
mal Krebs’ solution contained 124mM NaCl, 25mM NaHCO3,
3.0mMKCl, 1mMMgSO4–7H2O, 1.5mMNaH2PO4, 5mM glu-
cose, and 1.5mM CaCl2–2H2O. Composition of the “low glucose
challenge” solutions was identical to the normal Krebs’ solution
except that the concentration of glucose was decreased from 5
to 2.5mM, 1mM, or 0.5mM. Given that extracellular brain glu-
cose levels are∼30% that of plasma glucose (Silver and Erecinska,
1994), the range of normal extracellular brain glucose levels runs
between 0.5 and 2.5mM (Song et al., 2001). However, brain
areas such as the arcuate nucleus of the hypothalamus or the
NST, which border circumventricular organs, are predicted to be
exposed to glucose levels normally seen in the CSF (3.4mM) or
serum (5.5mM) (Levin et al., 2004). Therefore, we include 5mM
glucose as our “normal” glucose concentration for comparisons.
The “glucoprivic challenge” solution consisted of 5mM 2-
deoxy-D-glucose (2-DG; Sigma-Aldrich, St. Louis, MO) dissolved
in normal 5mM glucose Krebs’ solution. The osmolarity of
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the normal Krebs’, low glucose challenge, and glucoprivic chal-
lenge solutions were adjusted to 300 ± 3 mOsm with sucrose.
Tetrodotoxin (1µM TTX; Sigma-Aldrich, St Louis, MO) was
included in some low glucose challenge solutions. Bath applica-
tion of TTX has been shown to block approximately 95% of the
direct neuronal activation of NST astrocytes (McDougal et al.,
2011).
LIVE CELL CALCIUM IMAGING
Slices were transferred to a custom imaging chamber (Rogers and
Hermann, 2012b); perfused at a rate of 2.5mL/min with normal
Krebs’ maintained at a temperature of 32◦C. Slices were imaged
with a Nikon F1 fixed stage upright microscope equipped with a
Nikon Fast Scan laser confocal head and a Luca EMCCD camera
(Andor Technology, South Windsor, CT). Co-injection of CAG
and SR101 allows for discrimination of astrocytes and neurons at
the cellular level by comparing images captured using the 488 and
561 nm laser lines (McDougal et al., 2011). That is, at 488 nm,
both astrocytes and neurons pre-labeled with CAG will appear
green; at 561 nm, all astrocytes will also appear red. A single,
dual exposure image was collected just prior to and following
each experimental trial in order to confirm the cell types being
recorded (Figure 1).
Changes in intracellular calcium concentrations within CAG
pre-labeled NST-astrocytes and NST-neurons in response to dif-
ferent stimuli were recorded using the 488 nm laser line to
excite the CAG. Increases in intracellular calcium concentra-
tions are reflected as an increase in fluorescence and is indicative
of increased cellular activity. During experimental trials, time-
lapsed images of mixed fields of NST-astrocytes and neurons
were monitored for their responses to low glucose or glucoprivic
conditions.
EXPERIMENTAL DESIGN
Each slice was exposed to a single “experimental trial” which con-
sisted of three perfusion conditions of equal duration (i.e., 10min
for each condition). Slices were perfused with normal Krebs’ con-
taining 5mM glucose during the initial and final blocks of time.
The intervening block was the experimental condition [e.g., “time
control” consisting of continued perfusion with 5mM glucose
Krebs’, low glucose (i.e., 0.5, 1.0, or 2.5mM) or glucoprivic chal-
lenge (i.e., 5mM 2-DG with 5mM glucose Krebs’)]. Thus, each
cell functioned as its own control and transitional differences in
activity due to changes in available glucose (i.e., decreasing or
increasing) could also be monitored.
In order to rule out the possibility that neuronal synaptic
input to glia was responsible for the astrocytic responses to low-
glucose conditions, tetrodotoxin (TTX) was used to block action
potential-mediated communication between neurons and astro-
cytes (McDougal et al., 2011). For this study, we specifically chose
the 1mM glucose challenge, to ensure that the neurons would not
be compromised by very low glucose. In these experiments, TTX
(1µM) was present during all three perfusion periods [i.e., nor-
mal (5mM), low glucose challenge (1mM), and normal (5mM)
glucose]. The responses of cells during the low glucose challenge
plus TTX were then compared to responses of cells exposed to an
identical experimental trial that did not use TTX, i.e., identical
blocks of 0.5, 1 and 5mM profusion conditions without TTX.
Time-lapse images were analyzed using Nikon NIS-Elements
software. Each cell in a field was delineated as a region of inter-
est (ROI) and the average intensity of all pixels within each ROI
was calculated for each time point (Figure 1). These data were
exported to Microsoft Excel for analysis offline.
Relative changes in intracellular calcium in response to all
stimulation paradigms were quantified as percent changes in
fluorescence: (F/F)%, where F is the baseline fluorescence
intensity within an area of interest (e.g., the outline of an SR101-
labeled astrocyte) before stimulation, and F is the change
from this value resulting from stimulus-induced cellular activity
(Helmchen, 2000). Background fluorescence (i.e., non-responsive
areas in same field) was subtracted from both F and F. An
individual cell was considered to have responded to a given stim-
ulus if the stimulus induced a peak change in (F/F)% > 5%
(O’Malley et al., 2006; Rogers et al., 2006a,b; Hermann et al., 2009;
McDougal et al., 2011).
Parameters including average baseline fluorescence intensity,
peak intensity, as well as the onset of the response to the low
glucose or glucoprivic challenge were determined for each ROI.
These values were used to calculate: (a) latency to onset of
response, (b) peak responsemagnitude (percent increase in inten-
sity from baseline), (c) response offset (time at which the response
magnitude decayed to 1/e of the peak value; ∼37%), and (d)
response magnitude (area under the curve from response onset
to response offset) for each ROI. In order to verify the macro-
defined values, each was displayed graphically on a line plot of
intensity vs. time and visually inspected for accuracy.
The criteria of low-glucose (or 2DG) responder types:
• Positive: Peak response> 5% and AUC> 175 (F/F)%minute
andF/F values returned to 1/e of peak (∼37%) before the end
of the trial.
• Negative: Peak response < –5% and AUC< −175 (F/F)%
minute
• Sustained activation: Peak response > 5% and F/F values
failed to return to 1/e of peak (∼37%) before the end of
the trial. AUC is undefined in these cells because there is no
“stop time” which is defined as the time at which F/F values
returned to 1/e of peak (∼37%).
• Non-responders: Any cell which did not meet the above criteria.
DATA ANALYSIS
The cell type (i.e., astrocyte or neuron) represented by each
ROI was determined by the presence or absence of SR101 stain-
ing. The average values of three separate response parameters
(peak, latency, and response magnitude) were determined for
each cell type in each experimental condition, and then com-
pared statistically. Astrocytic response parameters across the three
concentrations of glucose were compared to neuronal response
parameters using two-way analysis of variance (i.e., cell type vs.
concentration of glucose). Separate analyses were made of the
average response parameters of astrocytes vs. neurons to a glu-
coprivic condition (i.e., 5mM glucose plus 5mM 2-DG) using
unpaired t-tests.
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Studies using TTX to determine if astrocytic responses were
secondary to neuronal activation used unpaired t-tests to evalu-
ate cellular response parameters of astrocytes or neurons during
the 1mM glucose challenge with vs. without TTX in the perfusion
Table 1 | Classification of cellular response patterns to low glucose
(top) or glucoprivic (bottom) challenges.
Low
glucose
positive (%)
Low
glucose
negative (%)
Low glucose
sustained
(%)
Low
glucose
NR (%)
Astrocytes
(263 total)
39 13 1 47
Neurons
(160 total)
37 11 1 51
2DG
positive (%)
2DG
negative (%)
2DG
sustained (%)
2DG NR
(%)
Astrocytes
(118 total)
42 8 3 47
Neurons
(81 total)
26 16 6 52
solution. All statistical analyses were performed using GraphPad
Prism software (GraphPad Software, La Jolla, CA); p-values <
0.05 were considered statistically significant.
RESULTS
A SUBSET OF NST-ASTROCYTES AND NEURONS RESPOND TO LOW
GLUCOSE CHALLENGE
Brainstem slices challenged by conditions of low glucose availabil-
ity (i.e., bath application of Krebs’ solution containing 0.5, 1.0,
or 2.5mM glucose) showed fluxes in intracellular calcium levels
in both NST-astrocytes and neurons. The cellular responses were
measured by changes in the fluorescent intensity of CAG relative
to individual baseline levels. The relative changes in cytoplas-
mic calcium were expressed as percent changes in fluorescence
[(F/F)%] of the CAG reporter dye, where F is the intensity of the
baseline fluorescence signal before stimulation, and F is the dif-
ference between the peak fluorescence intensity and the baseline
signal (Figures 2, 4, 5).
Both NST-astrocytes and neurons displayed one of four dis-
tinct response patterns as a result of exposure to each low glucose
challenge (Table 1). The most prevalent response pattern was the
“non-responder” which showed no response to conditions of low
glucose availability (47% of astrocytes; 51% of neurons). The sec-
ond largest category encountered was a “low glucose positive”
FIGURE 2 | Example of response patterns of low glucose-positive
astrocytes and neurons in the hindbrain slice preparation to low
glucose challenge. As seen in Figure 1, mixed fields of NST-astrocytes
and neurons were recorded using confocal live cell calcium imaging.
Changes in intracellular calcium levels were reflected as changes in
intensity of the fluorescent calcium indicator dye, Calcium Green 1-AM.
Both low glucose-positive (A) astrocytes and (B) neurons were activated
in response to a change in the extracellular glucose concentration from 5
to 0.5mM; this activation returned toward baseline levels following return
to 5mM glucose. [Traces in (A,B) are the average response of five
representative low glucose positive astrocytes and neurons, respectively].
Two-Way ANOVA: (C) Peak response and (D) response magnitude
demonstrated significant main effects attributed to the cell type
(p < 0.05) as well as significant main effects attributed to the
concentration of glucose (p < 0.05) (see also Figure 3). These main
effects are qualified due to the significant interactions between cell types
and glucose concentrations. Thus, NST-astrocytes were more responsive
than NST-neurons to low glucose conditions particularly at the 0.5mM
concentration. (E) Latency to onset of response to low glucose also
demonstrated a significant main effect attributed to cell type (p < 0.05);
astrocytes responded at 1.7 ± 0.2min (mean ± s.e.m.) compared to
neurons at 2.6 ± 0.2min. ∗P < 0.05.
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response pattern where cells showed an increase in intracellular
calcium concentrations when exposed to low glucose and baseline
levels of intracellular calcium concentrations returned following
the return to 5mM glucose Krebs’ solution (39% of astrocytes;
FIGURE 3 | Comparison of response parameters of NST-astrocytes and
-neurons to low glucose conditions. Subsets of both astrocytes and
neurons responded with increased activation, as seen by their change in
fluorescence, when exposed to lower glucose concentrations in the
perfusion solution. Two-Way ANOVA of the peak and magnitude of
astrocytic and neuronal responses to low glucose conditions revealed that
astrocytes were more responsive than neurons in (A) peak response and
(B) response magnitude, i.e., area under the curve [significant main effect
of cell type; F(1, 159) = 8.36 and 12.57, respectively; p < 0.05]. There were
significant main effects attributed to the concentration of glucose
[F(2, 159) = 8.40 and 18.57; respectively; p < 0.05]. These main effects are
qualified due to the significant interactions between cell types and glucose
concentrations [F(2, 159) = 5.24 and 4.99, respectively; p < 0.05].
Bonferroni post-hoc t-tests demonstrated that astrocytes and neurons
differ significantly in these response parameters when 0.5mM glucose was
in the perfusion bath; #p < 0.05. In astrocytes, these response parameters
at the 0.5mM glucose level where significantly different from those at the
1.0 and 2.5mM glucose levels; ∗p < 0.05.
37% of neurons) (Figures 2A,B; Table 1). The remaining cells
responded either with a decrease in intracellular calcium levels
and were characterized as “low glucose negative” (13% of astro-
cytes; 11% of neurons) or displayed an increase in intracellular
calcium signaling which failed to return to baseline levels follow-
ing the return to 5mM glucose levels. This last group is referred
to as “sustained activation” (1% of astrocytes; 1% of neurons;
Table 1).
RESPONSE TO LOW GLUCOSE CHALLENGE DIFFERED BASED ON CELL
TYPE AND GLUCOSE CONCENTRATION
Three response parameters were measured in “low glucose posi-
tive” astrocytes and neurons following exposure to each low glu-
cose challenge condition (0.5, 1.0, or 2.5mM); see Figure 3 and
Table 2. These parameters included: (1) response latency (time
between onset of challenge and response onset), (2) response
magnitude (area under the curve from response onset to response
offset), and (3) peak response (percent increase in CAG intensity
from baseline). Two-Way ANOVA revealed that latency to onset of
response demonstrated a significant main effect attributed to cell
type [F(1, 111) = 6.38, p < 0.05]. Latency to onset of response to
low glucose for astrocytes was 1.7± 0.2min (mean± SEM) com-
pared to neurons at 2.6 ± 0.2min. Peak response and response
magnitude also demonstrated significant main effects attributed
to the cell type [F(1, 159) = 8.36 and 12.57, respectively; p < 0.05]
as well as significant main effects attributed to the concentration
of glucose [F(2, 159) = 8.40 and 18.57; respectively; p < 0.05].
These main effects are qualified due to the significant interac-
tions between cell types and glucose concentrations [F(2, 159) =
5.24 and 4.99, respectively; p < 0.05]. Thus, astrocytes were more
responsive than neurons to low glucose conditions particularly at
the 0.5mM concentration (Figure 3).
Bonferroni post-hoc t-tests showed that astrocytes and neu-
rons differ in these response parameters to 0.5mM glucose in the
perfusion bath (Figure 2). Additionally, astrocytes demonstrated
significantly larger peak responses and response magnitudes to
0.5mM glucose compared to either 1.0 or 2.5mM glucose chal-
lenges (Figure 3).
A SUBSET OF NST-ASTROCYTES AND NEURONS RESPOND TO
GLUCOPRIVIC CHALLENGE
NST-astrocytes and neurons showed similar response patterns
during glucoprivic challenge where 5mM 2-DG was included
in the 5mM glucose-Krebs’ solution (Figure 4). Most astrocytes
(47%) and neurons (52%) were “non-responders” (Table 1). The
Table 2 | Response parameters of NST astrocytes and neurons responsive to low-glucose or 2DG conditions.
Condition Peak response(DF/F)% Magnitude of response N
(Area under the curve = change over time)
Astrocytes Neurons Astrocytes Neurons Astrocytes Neurons
5mM 2DG 15.5 ± 1.1 14.0 ± 1.0 2329 ± 228 2093 ± 229 56 21
0.5mM glucose 21.4 ± 1.8 10.4 ± 1.1 3005 ± 308 1224 ± 140 46 33
1.0mM glucose 10.1 ± 1.1 9.3 ± 1.8 678 ± 124 391 ± 60 35 17
2.5mM glucose 8.4 ± 0.7 7.8 ± 1.5 704 ± 139 391 ± 94 29 12
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FIGURE 4 | Activated response patterns of astrocytes and neurons in
the hindbrain slice preparation to glucoprivic challenge (i.e.,
2-DG-positive). Approximately 40% of NST-astrocytes and 25% of
NST-neurons responded to a glucoprivic solution consisting of 5mM
2-Deoxy-D-glucose (2-DG) dissolved in media containing normal (5mM)
glucose concentrations with an increase in activity (Tables 1, 2).
Examples of 2-DG-positive astrocytes and neurons activated in response
to the glucoprivic challenge are shown [Traces in (A,B) are the average
response of five representative 2-DG-positive astrocytes and neurons,
respectively]. The peak responses (C) and response magnitudes (D) were
similar in both astrocytes and neurons. However, these two cell types
differed in time to onset of response (E). NST-astrocytes averaged 1.4 ±
0.1min compared to the onset of NST-neuronal response at 2.2 ±
0.2min (∗p < 0.05).
next largest class was “2-DG positive” which displayed an increase
in intracellular calcium signaling during exposure to this glu-
coprivic condition that returned to baseline following washout
(42% of astrocytes; 26% of neurons). The remainder of cells could
be characterized as either “2-DG negative” (8% of astrocytes; 16%
of neurons) or “sustained activation” (3% of astrocytes; 6% of
neurons). Unpaired t-test comparisons revealed that astrocytes
had significantly shorter latencies to response onset compared
to neurons [1.4 ± 0.1min vs. 2.2 ± 0.2min; t(73) = 3.00; p =
0.0037]. There were no differences in peak response (15.5 ± 1.1%
vs. 14.0 ± 1.0%; astrocytes vs. neurons) or response magnitude
(2329 ± 228 vs. 2093 ± 229) between astrocytes and neurons
during glucoprivic challenge (Table 2).
LOW GLUCOSE SIGNALING IN NST-ASTROCYTES IS INDEPENDENT OF
NEURONAL SIGNALING
In order to rule out the possibility that neuronal synaptic input to
glia was responsible for the astrocytic responses to low-glucose
conditions, TTX was used to block action potential-mediated
communication between neurons and astrocytes (Figure 5).
Astrocytic peak responsiveness to a 1mM low glucose chal-
lenge was unaffected by TTX (15.3 ± 0.9% vs. 17.5 ± 1.7%),
although response magnitude was somewhat lower than con-
trol levels (991 ± 102 vs. 763 ± 116; Figures 5A,C,D). The
slight reduction in the size of the astrocytic responses in the
presence of TTX likely represents a loss of tonic neuronal acti-
vation of NST-astrocytes independent of glucose availability,
possibly mediated by glutamate release from vagal afferents
(McDougal et al., 2011).
In contrast, neuronal peak response and response magnitude
during the same low glucose challenge were significantly reduced
by TTX [peak response: 9.0 + 1.0% vs. 6.2 + 0.6%; t(17) = 2.422,
p = 0.013; magnitude: 652 ± 135 vs. 156 ± 37; t(17) = 3.043,
p = 0.004 (Figures 5B,E,F)]. NST neuronal calcium signaling in
response to low glucose challenge may be dependent on other
neuronal inputs or on modulation of the voltage-dependent
sodium conductance.
DISCUSSION
The dorsal medulla and NST have long been associated with
the central detection of the glucose availability and the con-
trol of the glycemic state (Bernard, 1855; Marty et al., 2007;
Grill and Hayes, 2012). Recent evidence is emerging in sup-
port of astrocytic involvement in glucose homeostasis (Young
et al., 2000; Guillod-Maximin et al., 2004; Marty et al., 2005).
Our present report provides evidence that astrocytes in the NST
respond to changes in glucose availability. Following exposure to
conditions of low glucose, a subset of NST-astrocytes and neu-
rons exhibit an increase in intracellular calcium signaling, this
is reversed following restoration of normal glucose availability.
Both the peak and magnitude of the astrocytic response var-
ied across different levels of low glucose availability. The size
of the neuronal response across the different glucose concen-
trations did not vary significantly. In comparison to adjacent
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FIGURE 5 | Astrocytic glucodetection is independent of neuronal
glucodetection. Mixed fields of NST-astrocytes and neurons were
exposed to 1mM glucose concentrations with and without the
presence of TTX in the perfusion bath. (A) The response of
NST-astrocytes to a low glucose challenge is shown by black
trace. The presence of 1µM TTX did not effectively alter the
astrocytic response (red trace). In contrast, (B) the response of
NST-neurons to a 1mM low glucose challenge was nearly
abolished in the presence of bath TTX (black trace = control
condition; red trace = TTX condition). Specifically, TTX did not
produce any statistically significant changes in astrocytic (C)
response magnitude or (D) peak response to low glucose
conditions. In contrast, TTX caused a statistically significant
reduction in both neuronal response magnitude (E) and peak
responsiveness (F) when compared to control neuronal responses
to low glucose. These results suggest that activation of
NST-astrocytes by low glucose challenge is independent of
neuronal gluco-sensation. NST neuronal calcium signaling in
response to low glucose challenge, on the other hand, may be
dependent on other neuronal inputs or on modulation of the
voltage-dependent sodium conductance. [∗p < 0.05; unpaired t-test
comparing response parameters in control vs. TTX condition. Traces
in (A,B) are the average response of five representative low
glucose positive astrocytes and neurons, respectively.]
neurons, astrocytes displayed larger peak responses and response
magnitudes, with a reduced latency to respond, following expo-
sure to 0.5mM glucose concentrations. Note that the activation
of astrocytes by reduced glucose was not a smooth linear func-
tion; increased activation occurred abruptly at 0.5mM glucose.
This behavior may be a reflection of the operation of an emer-
gency low threshold detection mechanism of the sort driving
counter-regulation in response to hypoglycemia (Song et al.,
2001; Marty et al., 2007). Furthermore, this astrocytic response
to low glucose challenge was independent of neuronal activa-
tion, as it was preserved during bath application of TTX. Note
that bath application of TTX nearly eliminated the neuronal
response to the same low glucose challenge. This suggests that low
glucose-mediated increases in neuronal cytoplasmic calcium are
produced as a consequence of action potential discharge (Gobel
and Helmchen, 2007). In addition, a subset of NST-astrocytes
and neurons exhibited an increase in intracellular calcium signal-
ing in response to bath application of the glucoprivic compound
2-DG (5mM). The onset of this response to glucoprivation
was more rapid in astrocytes as compared to adjacent neurons.
However, the latencies we observed for astrocytes and neurons
are similar to those reported previously for glucose sensitive cells
in the hypothalamus or hindbrain (Song et al., 2001; Kang et al.,
2004; Balfour et al., 2006). These observations suggest that NST-
astrocytes are important sensors of low glucose levels, and that
the chemodetection of glucose availability by NST-astrocytes may
play an important role in the autonomic regulation of glucose
homeostasis.
Astrocyte chemodetection is emerging as an important means
by which the brain mediates autonomic homeostasis. Astrocytes
in the ventral medulla increase cytoplasmic calcium in response to
elevated pCO2. This increase in glial calcium triggers a gliotrans-
mission mechanism that, in this instance, causes the release of
ATP onto adjacent respiratory rhythmogenic neurons (Gourine
et al., 2010; Marina et al., 2013). Our own work has shown that
astrocytes in the NST are activated by proteinase activated recep-
tor (PAR) agonists and, in turn, release glutamate onto adjacent
NST neurons (Hermann et al., 2009). In addition to glucoregula-
tory functions, the NST also suppresses gastric motility through
vago-vagal reflex connections with parasympathetic motor neu-
rons (Rogers andHermann, 2012a). This mechanismmay explain
in part why bleeding trauma and burn injuries (both conditions
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generate large amounts of PAR-activating thrombin) are associ-
ated with profound gastrointestinal stasis (Hermann et al., 2009).
It remains to be determined whether similar glial-neural inter-
actions are present between glucosensitive astrocytes and NST
neurons.
In addition, the mechanism by which a reduction in glu-
cose availability signals an increase in cytoplasmic calcium in
the NST-astrocyte also remains indeterminate. While astrocytic
expression of GLUT2 appears necessary for proper glucose
counter-regulation (Marty et al., 2005), the transduction mech-
anisms often coupled to GLUT2 produce changes in calcium
that run in the opposite direction to that observed for astrocytes.
For example, pancreatic beta cells respond with an increase in
intracellular calcium levels in response to increasing extracellu-
lar glucose. Here, glucose is transported through the GLUT2
transporter and metabolized via glycolysis and the tricarboxcylic
acid cycle to CO2, producing ATP. Increased cellular ATP energy
charge acts to phosphorylate and inactivate KATP channels, lead-
ing to depolarization, activation of voltage gated calcium channels
and ending in excitation—secretion coupling (Schuit et al., 2001;
Holsbeeks et al., 2004; Levin et al., 2004).
However, others have also reported that glucose restriction in
cultured astrocytes causes an increase in astrocytic cytoplasmic
calcium signals (Arnold, 2005). Similar to our present observa-
tions, this increase in cytoplasmic calcium is reversed with the
restoration of normal levels of glucose in the perfusion bath.
There is evidence suggesting that astrocytes are highly depen-
dent on glycolysis for ATP production; removal of glucose or
blocking glucose utilization may rapidly starve astrocytes of
glucose for ATP production (Kahlert and Reiser, 2000). With
impaired glycolysis and subsequent low ATP following low extra-
cellular glucose availability, the calcium-ATPase pump in the
endoplasmic reticulum (ER) of astrocytes fails and ER calcium
is released to the cytoplasm (Kahlert and Reiser, 2000; Arnold,
2005). While these results are consistent with our observations
in the slice preparation, it is not clear if this mechanism is actu-
ally responsible for the cytoplasmic calcium signal seen by our
laboratory in in situ NST-astrocytes. For example, the response
time for astrocytes in our NST slice preparation is about five-
fold faster than that reported for cultured hippocampal astro-
cytes.
One possibility for the acceleration of this mechanism rela-
tive to cultured astrocytes would be the expression of GLUT2
and glucokinase (GK) by glucosensitive NST-astrocytes. Glial
expression of both GLUT2 and GK has been reported previously
(Garcia et al., 2003; Arluison et al., 2004; Young and McKenzie,
2004; Millan et al., 2010), as well as the specific expression of
GLUT2 by a subset of NST-astrocytes (Leloup et al., 1994). Co-
expression of these proteins would permit cytoplasmic glucose
to flow backward through the GLUT2 transporter following a
reduction in extracellular glucose below intracellular glucose con-
centrations, thus speeding the elimination of fuel for glycolysis,
and therefore accelerating ER calcium release. Further studies uti-
lizing single cell qPCR could be employed to directly investigate
whether GLUT2 or GK is preferentially expressed by glucosen-
sitive NST-astrocytes as compared to non-glucoresponsive NST
astrocytes.
Another possibility which could account for the more rapid
astrocytic cytoplasmic calcium signals in our preparation is that
NST-astrocytes may contain a much more active low-glucose
detection mechanism via direct signaling of low glucose availabil-
ity by GLUT2. GLUT2 is the only mammalian glucose transporter
known to act as a “transceptor,” i.e., a protein which functions
as both a transporter and receptor. The receptor function of
mammalian GLUT2 is mediated by the large intracellular loop
between the 6th and 7th transmembrane domains (Guillemain
et al., 2000). Transgenic mice generated to knock down a GLUT2-
intracellular loop domain yielded animals that demonstrated an
inability to detect glucose but left the GLUT2-dependent glucose
transport unaffected (Stolarczyk et al., 2007, 2010). Depression of
glucose detection in these animals resulted in increased daily food
intake due to increased meal sizes.
The transporter function of GLUT2 has also been linked
to the activation of hepatic transcription factor, a carbohy-
drate response-element binding protein (Uyeda and Repa, 2006).
However, it seems unlikely that similar GLUT2-mediated tran-
scriptional regulation in NST-astrocytes could bring about the
large and rapid changes in intracellular calcium signaling we
observed in response to low glucose availability. Instead, it seems
more likely that there may be a direct interaction between the
intracellular loop domain of GLUT2 and signaling pathways
present in NST-astrocytes; although, at present, there is no infor-
mation available as to how it might function.
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